CliffBio
small molecule

THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER

THEOPHYLLINE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameTHEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Active ingredientTHEOPHYLLINE
Strength160MG/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJuly 1982
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.